EUVIMEDEUVIMED entdecken
Open Access

Treating Vaginal Relaxation Syndrome Using Erbium

Trisniartami Setyaningrum, Brahmana Askandar Tjokroprawiro, M Yulianto Listiawan, Budi Santoso, Cita Rosita Sigit Prakoeswa

Gynecology and Minimally Invasive Therapy · 2022-01 · 11 (1) · 23-27

DOI: 10.4103/gmit.gmit_141_20 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gynecology and Minimally Invasive Therapy, 2022-01. Verfasst von Trisniartami Setyaningrum und 4 weiteren Autor:innen. Beteiligte Einrichtung: Post Graduate Doctoral Program, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Vaginal relaxation syndrome (VRS) comprises vaginal laxity and stress urinary incontinence (SUI). Laser vaginal tightening (LVT) therapy using a fractional erbium:yttrium aluminum garnet (Er:YAG) 2.940 nm laser may represent a nonsurgical option for both complaints. This study evaluates the effectiveness and side effects of fractional Er:YAG laser therapy in VRS patients. The improvement in VRS was evaluated. Materials and Methods: This is a retrospective study analyzing the medical records of patients treated with fractional Er:YAG laser therapy in our private clinic in Surabaya, Indonesia. Objective questions were asked to rate patients’ satisfaction with the results of the therapy, namely dissatisfaction, and mild, moderate, or strong satisfaction. Statistical analysis used, data were input into tables in Microsoft Excel.

Results

Twenty-four VRS patients (54% with vaginal laxity, 33% with SUI, and 13% with vaginal laxity and SUI) were studied. Most of the patients were 36–45-year-old and had 2 children, and 79% of the patients had had a vaginal delivery. After 3 LVTs, mild satisfaction was observed in 15% of patients, moderate satisfaction was noted in 54% of patients, and high satisfaction was noted in 31% of patients. Among 11 patients with SUI, 36% recovered after the first LVT, and 100% recovered after the second LVT therapy. One patient experienced mild fluor albus as a side effect.

Conclusion

LVT therapy with a fractional Er:YAG laser was determined to be effective and safe as a treatment for VRS.

Schlagwörter

Stichwörter der Autor:innen

Erbium:yttrium aluminum garnet fractional laserstress urinary incontinencevaginal laxityvaginal relaxation syndrome

Autor:innen und Institutionen

  • Post Graduate Doctoral Program, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.
  • Department of Dermatology and Veneorolgy, Faculty of Medicine, Dr. Soetomo General Academic Hospital, Universitas Airlangga, Surabaya, Indonesia.
  • Department of Obstetric and Gynecology, Faculty of Medicine, Dr. Soetomo General Academic Hospital, Universitas Airlangga, Surabaya, Indonesia.

Zitieren

APA

Setyaningrum, T., Tjokroprawiro, B. A., Listiawan, M. Y., Santoso, B., & Prakoeswa, C. R. S. (2022). Treating Vaginal Relaxation Syndrome Using Erbium. Gynecology and Minimally Invasive Therapy, 11(1), 23-27. https://doi.org/10.4103/gmit.gmit_141_20

Vancouver

Setyaningrum T, Tjokroprawiro BA, Listiawan MY, Santoso B, Prakoeswa CRS. Treating Vaginal Relaxation Syndrome Using Erbium. Gynecology and Minimally Invasive Therapy. 2022;11(1):23-27. doi:10.4103/gmit.gmit_141_20

BibTeX
@article{Setyaningrum2022,
  author = {Setyaningrum, Trisniartami and Tjokroprawiro, Brahmana Askandar and Listiawan, M Yulianto and Santoso, Budi and Prakoeswa, Cita Rosita Sigit},
  title = {Treating Vaginal Relaxation Syndrome Using Erbium},
  journal = {Gynecology and Minimally Invasive Therapy},
  year = {2022},
  volume = {11},
  number = {1},
  pages = {23--27},
  doi = {10.4103/gmit.gmit_141_20}
}
Kostenlos starten →